A Novel (−)‑(2S)‑7,4′‑Dihydroxyfavanone Compound for Treating Age-Related Diabetes Mellitus through Immunoinformatics-Guided Activation of CISD3
Age-related diabetes mellitus is increasingly linked to mitochondrial dysfunction. This research identifies CID3, a key regulator of mitochondrial stability, whose activation can mitigate oxidative stress and telomere shortening major contributors to diabetes and ageing.